New imaging agent shows promise for non-invasive endometriosis diagnosis
Sex
University of Oxford Apr 29 2026 The Nuffield Department of Women's & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited announces the publication of Phase 2 data in The Lancet Obstetrics and Gynaecology . The findings highlight the potential of the novel molecular imaging agent, 99mTc-maraciclatide, as a non-invasive tool for the diagnosis and monitoring of endometriosis. The paper published online today highlights that 99m Tc-maraciclatide has potential as:
astăzi